Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Oxford Health Alliance (OxHA) was a global non-profit organization dedicated to reducing the prevalence of non-communicable diseases (NCDs). Founded in 2003, it focused on the "3-4-50" framework, which highlights how three key behaviors—tobacco use, poor diet, and physical inactivity—contribute to four major diseases (cardiovascular disease, cancer, chronic lung disease, and diabetes) that account for over 50% of deaths worldwide. The alliance worked through advocacy, research, and multi-sectoral partnerships to promote healthier lifestyles and systemic policy changes. It was closely associated with the University of Oxford and received significant founding support from Novo Nordisk. OxHA played a significant role in raising global awareness of the NCD epidemic before its functions were largely integrated into other global health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Health Alliance.